Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $37.41 Analyst target: $71.94 Upside: 92.30%
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat patients with neurological disorders in Canada. The company is headquartered in Burnaby, Canada.
See the full interactive analysis & chart →Informational only — not investment advice.